Topics

PGIM Company Profile

21:35 EDT 21st September 2019 | BioPortfolio

PGIM’s businesses offer a range of investment solutions for retail and institutional investors around the world across a broad range of asset classes, including fundamental equity, quantitative equity, public fixed income, private fixed income, real estate and commercial mortgages. Its businesses have offices in 16 countries across five continents and had $963 billion in assets under management as of December 31, 2015. For more information, please visit www.pgim.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

PGIM

PGIM’s businesses offer a range of investment solutions for retail and institutional investors around the world across a broad range of asset classes, including fundamental e...

More Information about "PGIM" on BioPortfolio

We have published hundreds of PGIM news stories on BioPortfolio along with dozens of PGIM Clinical Trials and PubMed Articles about PGIM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PGIM Companies in our database. You can also find out about relevant PGIM Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record